HCA Healthcare, Inc.
HCANYSE · SIC 8062
$371.18
↓ -3.8%Jul 17 close · end-of-day
Price
1Y↑ +3.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$84.1B
Enterprise Value
$131.2B
P/E
12.8
P/S
1.1
P/B
—
EV/EBITDA
—
PEG
0.9
FCF Yield
9.4%
Dividend Yield
0.8%
Revenue (TTM)
$76.4B
Net Income (TTM)
$6.8B
Free Cash Flow (TTM)
$7.9B
Gross Margin
—
Operating Margin
—
Net Margin
8.9%
ROE
-107.8%
ROIC
—
Debt / Equity
-7.6
Net Cash
-$47.1B
Return 1Y
+3.1%
Company profile
HCA Healthcare, Inc. provides health care services company in the United States. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. The company operates inpatient care, intensive care, cardiac care, diagnostic, and emergency services.
- CEO
- Samuel N. Hazen
- Sector
- Services
- Industry
- Healthcare
- Employees
- 294,000
- Headquarters
- Tennessee
- Website
- hcahealthcare.com
Management & directors
- Marks Mike AEVP and CFO
- Mcalevey Michael REVP & Chief Legal & Admin Off.
- Berres JenniferSVP & Chief Human Res. Officer
- Wyatt Christopher F.SVP & Controller
- Cuffe Michael S.EVP and Chief Clinical Officer
- Foster Jon MEVP and COO
- Hazen Samuel NCEO
- Rossitto EricaSVP & Chief Nurse Executive
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-10-13
HCA Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$19.1B↑ +4.3%
Diluted EPS$7.15↑ +10.9%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $51.5B | $58.8B | $60.2B | $65.0B | $70.6B | $75.6B |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $3.8B | $7.0B | $5.6B | $5.2B | $5.8B | $6.8B |
| Diluted EPS | $10.93 | $21.16 | $19.15 | $18.97 | $22.00 | $28.33 |
| Operating cash flow | $9.2B | $9.0B | $8.5B | $9.4B | $10.5B | $12.6B |
| Free cash flow | $6.4B | $5.4B | $4.1B | $4.7B | $5.6B | $7.7B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
| Line item | Q2 '24 | Q3 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5B | $17.5B | $18.3B | $18.3B | $18.6B | $19.2B | $19.5B | $19.1B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $1.5B | $1.3B | $1.4B | $1.6B | $1.7B | $1.6B | $1.9B | $1.6B |
| Diluted EPS | $5.53 | $4.88 | $5.66 | $6.45 | $6.83 | $6.96 | $8.09 | $7.15 |
| Operating cash flow | $2.0B | $3.5B | $2.6B | $1.7B | $4.2B | $4.4B | $2.4B | $2.0B |
| Free cash flow | $690.0M | $2.3B | $1.3B | $660.0M | $3.0B | $3.1B | $870.0M | $895.0M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | 8.4% | 7.3% | 7.9% | 8.8% | 8.9% | 8.6% | 9.6% | 8.5% |
Company news
Jul 17, 2026
Jul 15, 2026
- 5d agoHCA Healthcare (HCA) Stock Still Trades At A Discount Despite A 52% Returnfinance.yahoo.com
- 5d agoWhy Elevance Earnings Gave Health Insurance Stocks A Cold; UNH Up Nextfinance.yahoo.com
- 5d agoHCA Healthcare (HCA) Stock Sees Modest Fair Value Cut As Policy Risks Temper Growth Viewsfinance.yahoo.com
- 5d agoBarclays Downgrades HCA Healthcare (HCA) – Here’s Whyfinance.yahoo.com
- 5d agoWhy HCA Healthcare (HCA) Is Down 14.1% After Cutting 2026 Guidance on Uninsured Patient Shiftfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-07 | Marks Mike A· EVP and CFO | Gift | 3,336 | $0.00 | $0.00 | filing |
| 2026-04-28 | Frist William R | Award | 809 | $0.00 | $0.00 | filing |
| 2026-04-28 | FRIST THOMAS F III | Award | 1,041 | $0.00 | $0.00 | filing |
| 2026-04-28 | Smith Andrea B | Award | 509 | $0.00 | $0.00 | filing |
| 2026-04-28 | Riley Wayne Joseph | Award | 509 | $0.00 | $0.00 | filing |
| 2026-04-28 | MICHELSON MICHAEL W | Award | 925 | $0.00 | $0.00 | filing |
| 2026-04-28 | Johnston Hugh F | Award | 809 | $0.00 | $0.00 | filing |
| 2026-04-28 | CHIDSEY JOHN | Award | 809 | $0.00 | $0.00 | filing |
| 2026-04-28 | DEPARLE NANCY ANN | Award | 509 | $0.00 | $0.00 | filing |
| 2026-02-18 | McAlevey Michael R· EVP & Chief Legal & Admin Off. | Sale | 1,694 | $533.37 | $903,536.74 | filing |
| 2026-02-13 | McAlevey Michael R· EVP & Chief Legal & Admin Off. | Tax withholding | 3,306 | $540.29 | $1.8M | filing |
| 2026-02-13 | McAlevey Michael R· EVP & Chief Legal & Admin Off. | Option exercise | 5,000 | $236.61 | $1.2M | filing |
| 2026-02-11 | Berres Jennifer· SVP & Chief Human Res. Officer | Sale | 4,010 | $526.16 | $2.1M | filing |
| 2026-02-11 | Wyatt Christopher F.· SVP & Controller | Sale | 4,000 | $505.00 | $2.0M | filing |
| 2026-02-11 | Berres Jennifer· SVP & Chief Human Res. Officer | Sale | 4,010 | $503.00 | $2.0M | filing |
| 2026-02-10 | HAZEN SAMUEL N· CEO | Tax withholding | 21,323 | $502.05 | $10.7M | filing |
| 2026-02-10 | Foster Jon M· EVP and COO | Tax withholding | 5,888 | $502.05 | $3.0M | filing |
| 2026-02-10 | Cuffe Michael S.· EVP and Chief Clinical Officer | Tax withholding | 3,501 | $502.05 | $1.8M | filing |
| 2026-02-10 | McAlevey Michael R· EVP & Chief Legal & Admin Off. | Tax withholding | 3,006 | $502.05 | $1.5M | filing |
| 2026-02-10 | Berres Jennifer· SVP & Chief Human Res. Officer | Tax withholding | 2,515 | $502.05 | $1.3M | filing |
| 2026-02-10 | Marks Mike A· EVP and CFO | Tax withholding | 1,690 | $502.05 | $848,464.50 | filing |
| 2026-02-10 | Wyatt Christopher F.· SVP & Controller | Tax withholding | 1,034 | $502.05 | $519,119.70 | filing |
| 2026-02-10 | Rossitto Erica· SVP & Chief Nurse Executive | Tax withholding | 418 | $502.05 | $209,856.90 | filing |
| 2026-02-10 | Foster Jon M· EVP and COO | Award | 15,696 | $0.00 | $0.00 | filing |
| 2026-02-10 | Rossitto Erica· SVP & Chief Nurse Executive | Award | 1,676 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.